Marc Belsky Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Marc Belsky.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Marc Belsky. Marc Belsky is a VP Finance and CAO in CELL GENESYS INC ($CEGE) and a Senior Vice President and CFO in FIVE PRIME THERAPEUTICS INC ($FPRX) and a SVP and CFO in FIVE PRIME THERAPEUTICS INC ($FPRX) and a CFO in Kezar Life Sciences, Inc. ($KZR) and a Chief Financial Officer in Kezar Life Sciences, Inc. ($KZR).
Address: 500 FORBES BLVD. SOUTH SAN FRANCISCO 94080 CA
Companies in which Marc Belsky is an Insider
CELL GENESYS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Belsky: VP Finance and CAO
Holdings: 6,456 shares
Latest Transaction: Aug 01 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
FIVE PRIME THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Belsky: Senior Vice President and CFO, SVP and CFO
Holdings: 16,314 shares
Current Value: $740,329
Latest Transaction: Feb 28 2018
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kezar Life Sciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Marc Belsky: CFO, Chief Financial Officer
Holdings: 15,384 shares
Latest Transaction: Jan 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Marc Belsky
Sentiment: All, CEGE, FPRX, KZR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 11 2021 | KZR | Kezar Life Science ... | Belsky Marc | CFO | Option Exercise | A | 5.45 | 220,000 | 1,199,000 | 220,000 | |
| Feb 05 2020 | KZR | Kezar Life Science ... | Belsky Marc | CFO | Buy | P | 2.60 | 15,384 | 39,998 | 15,384 | 0 to 15.4 K |
| Jan 13 2020 | KZR | Kezar Life Science ... | Belsky Marc | CFO | Option Exercise | A | 3.29 | 90,000 | 296,100 | 90,000 | |
| Jan 13 2020 | KZR | Kezar Life Science ... | Belsky Marc | CFO | Option Exercise | A | 3.29 | 90,000 | 296,100 | 90,000 | |
| Nov 13 2019 | KZR | Kezar Life Science ... | Belsky Marc | CFO | Buy | P | 2.76 | 800 | 2,207 | 2,000 | 1.2 K to 2 K (+66.67 %) |
| Nov 13 2019 | KZR | Kezar Life Science ... | Belsky Marc | CFO | Buy | P | 2.76 | 800 | 2,207 | 2,000 | 1.2 K to 2 K (+66.67 %) |
| Sep 10 2019 | KZR | Kezar Life Science ... | Belsky Marc | Chief Financial Off ... | Option Exercise | A | 3.38 | 60,000 | 202,800 | 60,000 |